Abstract
Opioid peptides and their G protein-coupled receptors (GPCRs) are important regulators within the cardiovascular system, implicated in modulation of electrophysiological function, heart rate, myocardial inotropy, vascular function, and cellular stress resistance. The opioid system is also involved in cardiovascular development, adaptation to injury and effects of advanced age. The significant roles of opioids are emphasized by the observation that the heart produces prodynorphin and proenkephalin, which are enzymatically processed from small to large active polypeptides. Indeed, depending on species, cardiac preproenkephalin mRNA levels are comparable to or higher than those found in the central nervous system. This review highlights and discusses current knowledge and recent findings regarding physiological and pathophysiological modulation of the heart and vessels by the opioid receptor system.
Keywords: Opioid peptide, opioid receptor, cardiovascular system, cytoprotection, G protein-coupled receptors (GPCRs), electrophysiological function, heart rate, myocardial inotropy, vascular function, cellular stress resistance.
Current Pharmaceutical Design
Title:Non-Analgesic Effects of Opioids: Cardiovascular Effects of Opioids and their Receptor Systems
Volume: 18 Issue: 37
Author(s): John P. Headrick, Salvatore Pepe and Jason N. Peart
Affiliation:
Keywords: Opioid peptide, opioid receptor, cardiovascular system, cytoprotection, G protein-coupled receptors (GPCRs), electrophysiological function, heart rate, myocardial inotropy, vascular function, cellular stress resistance.
Abstract: Opioid peptides and their G protein-coupled receptors (GPCRs) are important regulators within the cardiovascular system, implicated in modulation of electrophysiological function, heart rate, myocardial inotropy, vascular function, and cellular stress resistance. The opioid system is also involved in cardiovascular development, adaptation to injury and effects of advanced age. The significant roles of opioids are emphasized by the observation that the heart produces prodynorphin and proenkephalin, which are enzymatically processed from small to large active polypeptides. Indeed, depending on species, cardiac preproenkephalin mRNA levels are comparable to or higher than those found in the central nervous system. This review highlights and discusses current knowledge and recent findings regarding physiological and pathophysiological modulation of the heart and vessels by the opioid receptor system.
Export Options
About this article
Cite this article as:
P. Headrick John, Pepe Salvatore and N. Peart Jason, Non-Analgesic Effects of Opioids: Cardiovascular Effects of Opioids and their Receptor Systems, Current Pharmaceutical Design 2012; 18 (37) . https://dx.doi.org/10.2174/138161212803582360
DOI https://dx.doi.org/10.2174/138161212803582360 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of CD73 in Disease: Promising Prognostic Indicator and Therapeutic Target
Current Medicinal Chemistry Induction and Escalation Therapies in Multiple Sclerosis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Diabetic Cardiovascular Disease – AMP-Activated Protein Kinase (AMPK) as a Therapeutic Target
Cardiovascular & Hematological Agents in Medicinal Chemistry Tapping into Mitochondria to Find Novel Targets for Diabetes Complications
Current Drug Targets The Mechanism of Carvedilol in Experimental Viral Myocarditis
Current Pharmaceutical Design Gemcitabine-Related Atrial Fibrillation: A Case Report and Review of the Literature
Current Drug Safety Characterization of Supraventricular Tachycardia in Infants: Clinical and Instrumental Diagnosis
Current Pharmaceutical Design Apelin in the Control of Body Fluid Homeostasis and Cardiovascular Functions
Current Pharmaceutical Design Invasive and Noninvasive Assessment of Exercise-induced Ischemic Diastolic Response Using Pressure Transducers
Current Cardiology Reviews Mechanisms Explaining the Influence of Subclinical Hypothyroidism on the Onset and Progression of Chronic Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Regulation of Oxidative Stress and Cardioprotection in Diabetes Mellitus
Current Cardiology Reviews Pharmacogenomics of the Human ATP-Binding Cassette Transporter ABCG2
Current Pharmacogenomics MicroRNAs in the Management of Heart Failure
Current Medicinal Chemistry How to Recognize Epicardial Origin of Ventricular Tachycardias?
Current Cardiology Reviews Chronic Complications of Diabetes Mellitus: A Mini Review
Current Diabetes Reviews Patent Selections
Recent Patents on Regenerative Medicine Immunophilins and Coupled Gating of Ryanodine Receptors
Current Topics in Medicinal Chemistry Inflammatory Syndrome in Chronic Kidney Disease: Pathogenesis and Influence on Outcomes
Inflammation & Allergy - Drug Targets (Discontinued) PARADIGM - HF: The Rise of the Arnis
Reviews on Recent Clinical Trials Genomic and Non-genomic Effects of Aldosterone
Current Signal Transduction Therapy